Boston, Massachusetts
United States
59
2026-03-26
The entities that hold a legal rights for patent applications filed by inventor GOUTOPOULOS Andreas:
Andreas GOUTOPOULOS from Boston, US has applied for patents for these inventions. The list has both pending applications and granted patents:
ACSS2 INHIBITORS AND METHODS OF USE THEREOF
#2 | 2026-02-26PARG INHIBITORY COMPOUND
#3 | 2025-06-12ACSS2 INHIBITORS AND METHODS OF USE THEREOF
#4 | 2025-01-02N,N-DIMETHYL-4-(7-(N-(1-METHYLCYCLOPROPYL)SULFAMOYL)-IMIDAZO[1,5-A]PYRIDIN-5-YL)PIPERAZINE-1-CARBOXAMIDE DERIVATIVES AND THE CORRESPONDING PYRAZOLO[1,5-A]PYRIDINE DERIVATIVES AS PARG INHIBITORS FOR THE TREATMENT OF CANCER
#5 | 2024-12-26PARG INHIBITORY COMPOUNDS
#6 | 2023-06-08IMIDAZOLE 3-OXIDE DERIVATIVE BASED ACSS2 INHIBITORS AND METHODS OF USE THEREOF
#7 | 2023-03-16GLUCOSE UPTAKE INHIBITORS AND USES THEREOF
#8 | 2023-03-16ACSS2 INHIBITORS AND METHODS OF USE THEREOF
#9 | 2022-09-29ACSS2 inhibitors and methods of use thereof
#10 | 2019-08-29ACSS2 inhibitors and methods of use thereof
#11 | 2019-08-01Heteroaryl compounds as BTK inhibitors and uses thereof
#12 | 2018-08-30Compositions and methods for the production of pyrimidine and pyridine compounds with BTK inhibitory activity
#13 | 2018-08-23Substituted pyrido[3,4-d]pyrimidines and pyrido[4,3-d]pyrimidines as p70S6K inhibitors
#14 | 2017-12-28Dihydropyrazoles
#15 | 2017-09-28Macrocyclic compounds as IRAK1/4 inhibitors and uses thereof
#16 | 2017-06-22Pyridazinone macrocycles as IRAK inhibitors and uses thereof
#17 | 2017-05-18Compositions and methods for the production of pyrimidine and pyridine compounds with BTK inhibitory activity
#18 | 2017-03-23Indolizine derivatives and their use in neurodegenerative diseases
#19 | 2017-03-16Dihydropyrazoles
#20 | 2017-01-26Benzamides
#21 | 2016-12-15Heterocycles as modulators of kinase activity
#22 | 2016-11-24Substituted benzo[d][1,2,3]triazines as p70S6K inhibitors
#23 | 2016-08-11Pyridazinone macrocycles as IRAK inhibitors and uses thereof
#24 | 2016-08-11Macrocyclic compounds as IRAK1/4 inhibitors and uses thereof
#25 | 2016-04-07Heteroaryl compounds as BTK inhibitors and uses thereof
#26 | 2016-02-04Indolizine derivatives and their use in neurodegenerative diseases
#27 | 2016-01-28Benzamides
#28 | 2016-01-21Heterocycles as modulators of kinase activity
#29 | 2015-09-17Compositions and methods for the production of pyrimidine and pyridine compounds with BTK inhibitory activity
#30 | 2015-09-17Substituted pyrido[3,2-d]pyrimidines for treating cancer
#31 | 2015-08-13Pyrimidine imidazole amines as modulators of kinase activity
#32 | 2015-01-15Glycosidase inhibitors
#33 | 2014-10-02Dihydropyrazoles
#34 | 2014-08-28Pyrano [3,2-D][1,3]thiazole as glycosidase inhibitors
#35 | 2014-08-14Pyrido-pyrimidine derivatives
#36 | 2014-06-12Compositions and methods for the production of pyrimidine and pyridine compounds with BTK inhibitory activity
#37 | 2014-04-17Amino azaheterocyclic carboxamides
#38 | 2014-02-203-arylamino pyridine derivatives
#39 | 2013-09-26Quinazoline carboxamide azetidines
#40 | 2013-07-18Phenylamino isonicotinamide compounds
#41 | 2013-07-04Dihydropyrazoles
#42 | 2013-06-06Piperazine derivatives and methods of use
#43 | 2013-01-24Benzamides
#44 | 2012-11-223-arylamino pyridine derivatives
#45 | 2012-07-26Bicyclic urea compounds
#46 | 2012-02-23Amino azaheterocyclic carboxamides
#47 | 2011-12-01Macrocyclics pyrimidines as aurora kinase inhibitors
#48 | 2011-11-03NAPHTHYRIDINONES AS PROTEIN KINASE INHIBITORS
#49 | 2011-09-153-arylamino pyridine derivatives
#50 | 2011-07-28Phenylamino isonicotinamide compounds
#51 | 2011-03-03Protein kinase inhibitors and use thereof
#52 | 2010-10-07Arylamino N-heteraryl compounds as MEK inhibitors
#53 | 2009-04-093-arylamino pyridine derivatives
#54 | 2007-12-20Novel 4-Arylamino Pyridone Derivatives as Mek Inhibitors for the Treatment of Hyper-Proliferative Disorders
#55 | 2007-12-13Heteroaryl-substituted arylaminopyridine derivatives as MEK inhibitors
#56 | 2007-12-13Arylamino N-heteroaryl compounds as MEK inhibitors
#57 | 2007-10-02Retro-anandamides, high affinity and stability cannabinoid receptor ligands
#58 | 2006-10-05Piperazine derivatives and methods of use
#59 | 2005-01-27Inhibitors of the anandamide transporter
54716 ⎘